Prevention and treatment options for postoperative Crohn's disease: A clinical dilemma

Gastroenterology and Hepatology

Volumn 5, Issue 8, 2009, Pages 581-588

  Clarke, Kofi ^a   Regueiro, Miguel ^a,b,c  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b Inflammatory Bowel Disease Center   (United States)

^c Gastroenterology Hepatology and Nutrition Fellowship Program   (United States)

Author keywords

5 aminosalicylates; Crohn's disease; Immunomodulators; Infliximab; Postoperative recurrence

Indexed keywords

AZATHIOPRINE; BUDESONIDE; CALGRANULIN; INFLIXIMAB; LACTOBACILLUS JOHNSONII LA1; LACTOFERRIN; MERCAPTOPURINE; MESALAZINE; METHOTREXATE; METRONIDAZOLE; NITROIMIDAZOLE; ORNIDAZOLE; PLACEBO; PREBIOTIC AGENT; PREDNISONE; PROBIOTIC AGENT; SALAZOSULFAPYRIDINE; SYNBIOTIC AGENT; UNCLASSIFIED DRUG;

ACCURACY; CLINICAL EVALUATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CROHN DISEASE; DISEASE ACTIVITY; DRUG DOSE COMPARISON; DRUG EFFICACY; DRUG TOLERABILITY; ECHOGRAPHY; ENDOSCOPY; FOLLOW UP; HUMAN; INTESTINE RESECTION; PATIENT MONITORING; PLACEBO EFFECT; PRACTICE GUIDELINE; PROPHYLAXIS; RANDOMIZED CONTROLLED TRIAL; RECURRENCE RISK; RECURRENT DISEASE; REVIEW; RISK FACTOR; SENSITIVITY AND SPECIFICITY; TREATMENT OUTCOME;

EID: 70350155743     PISSN: 15547914     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (50)

1. Sachar DB. The problem of postoperative recurrence of Crohn's disease. Med Clin North Am. 1990;74:183-188.
2. Cosnes J, Nion-Larmurier I, Beaugerie L, Afchain P, Tiret E, Gendre JP. Impact of increasing use of immunosuppressants in Crohn's disease on the need for intestinal surgery. Gut. 2005;54:237-241. (Pubitemid 40139240)
3. 3- Bennell O, Lapidus A, Hellers G. Risk factors for surgery and postoperative recurrence in Crohn's disease. Ann Surg. 2000;231:38-45. (Pubitemid 30043937)
4. D'Haens GR, Geboes K, Peeters M, Baert F, Penninckx F, Rutgeerts P. Early lesions of recurrent Crohn's disease caused by infusion of intestinal contents in excluded ileum. Gastroenterology. 1998;114:262-267. (Pubitemid 28093532)
5. Olaison G, Smedh K, Sjodahl R. Natural course of Crohn's disease after ileocolic resection: endoscopically visualized ileal ulcers preceding symptoms. Gut. 1992;33:331-335.
6. Rutgeerts P, Geboes K, Vantrappen G, Beyls J, Kerremans R, Hiele M. Predictability of the postoperative course of Crohn's disease. Gastroenterology. 1990;99:956-983. (Pubitemid 20338451)
7. Kurer MA, Stamou KM, Wilson TR, Bradford IM, Leveson SH. Early symptomatic recurrence after intestinal resection in Crohn's disease is unpredictable. Colorectal Dis. 2007;9:567-571.
8. Welsch T, Hinz U, Löffler T, Muth G, Herfarth C, et al. Early re-laparotomy for post-operative complications is a significant risk factor for recurrence after ileocaecal resection for Crohn's disease. Int J Colorectal Dis. 2007;22:1043-1049. (Pubitemid 47500246)
9. Scarpa M, Ruffolo C, Bertin E, Polese L, Filosa T, et al. Surgical predictors of recurrence of Crohn's disease after ileocolonic resection. Int J Colorectal Dis. 2007;22:1061-1069. (Pubitemid 47500248)
10. Reese GE, Nanidis T, Borysiewicz C, Yamamoto T, Orchard T, Tekkis PP. The effect of smoking after surgery for Crohn's disease: a meta-analysis of observational studies. Int J Colorectal Dis. 2008;23:1213-1221.
11. Renda MC, Orlando A, Civitavecchia G, Criscuoli V, Maggio A, et al. The role of CARD15 mutations and smoking in the course of Crohn's disease in a Mediterranean area. Am J Gastroenterol. 2008;103:649-655.
12. Yamamoto T, Nakahigashi M, Umegae S, Kitagawa T, Matsumoto K. Impact of long-term enteral nutrition on clinical and endoscopic recurrence after resection for Crohn's disease: A prospective, non-randomized, parallel, controlled study. Aliment Pharmacol Ther. 2007:25:67-72. (Pubitemid 44902865)
13. Michelassi F, Balestracci T, Chappell R, Block GE. Primary and recurrent Crohn's disease: experience with 1379 patients. Ann Surg. 1991;214:230-240.
14. Sutherland LR, Ramcharan S, Bryant H, Fick G. Effect of cigarette smoking on recurrence of Crohn's disease. Gastroenterology. 1990;98:1123-1128. (Pubitemid 20143093)
15. Cosnes J, Carbonnel F, Beaugerie L, Le Quintrec Y, Gendre JP. Effects of cigarette smoking on the long-term course of Crohn's disease. Gastroenterology. 1996;110:424-431. (Pubitemid 26043875)
16. Mekhjian HS, Switz DM, Watts HD, Deren JJ, Katon RM, Beman FM. National Cooperative Crohn's Disease Study: factors determining recurrence of Crohn's disease after surgery. Gastroenterology. 1979;77:907-913. (Pubitemid 9242052)
17. Caprilli R, Corrao G, Taddei G, Tonelli F, Torchio P, Viscido A. Prognostic factors for postoperative recurrence of Crohn's disease. Gruppo Italiano per lo Studio del Colon e del Retto (GISC). Dis Colon Rectum. 1996;39:335-341. (Pubitemid 26091341)
18. Greenstein AJ, Lachman P, Sachar DB, Springhorn J, Heimann T, et al. Perforating and nonperforating indications for repeated operations in Crohn's disease: evidence for two clinical forms. Gut. 1988;29:588-592. (Pubitemid 18145437)
19. Lautenbach E, Berlin JA, Lichtenstein GR. Risk factors for early postoperative recurrence of Crohn's disease. Gastroenterology. 1998;115:259-267. (Pubitemid 28363417)
20. Avidan B, Sakhnini E, Lahat A, Lang A, Koler M, et al. Risk factors regarding the need for a second operation in patients with Crohn's disease. Digestion. 2005;72:563-571. (Pubitemid 41820810)
21. McLeod RS, Wolff BG, Steinhart AH, Carryer PW, O'Rourke K, et al. Prophylactic mesalamine treatment decreases postoperative recurrence of Crohn's disease. Gastroenterology. 1995;109:404-413.
22. Scarpa M, D'Incà R, Basso D, Ruffolo C, Polese L, et al. Fecal lactoferrin and calprotectin after ileocolonic resection for Crohn's disease. Dis Colon Rectum. 2007;50:861-869. (Pubitemid 46870452)
23. Calabrese E, Petruzziello C, Onali S, Condino G, Zorzi F, et al. Severity of postoperative recurrence in Crohn's disease: Correlation between endoscopic and sonographic findings. Inflamm Bowel Dis. 2009 Apr 30. [Epub ahead of print].
24. Biancone L, Calabrese E, Petruzziello C, Onali S, Caruso A, et al. Wireless capsule endoscopy and small intestine contrast ultrasonography in recurrence of Crohn's disease. Inflamm Bowel Dis. 2007;13:1256-1265. (Pubitemid 47597773)
25. Gralnek IM, Defranchis R, Seidman E, Leighton JA, Legnani P, Lewis BS. Development of a capsule endoscopy scoring index for small bowel mucosal inflammatory change. Aliment Pharmacol Ther. 2008;27:146-154. (Pubitemid 350256605)
26. Renna S, Cammà C, Modesto I, Cabibbo G, Scimeca D, et al. Meta-analysis of the placebo rates of clinical relapse and severe endoscopic recurrence in postoperative Crohn's disease. Gastroenterology. 2008;135:1500-1509.
27. Cao Y, Gao F, Liao C, Tan A, Mo Z. Meta-analysis of medical treatment and placebo treatment for preventing postoperative recurrence in Crohn's disease (CD). Int J Colorectal Dis. 2009;24:509-520.
28. Marteau P, Lémann M, Seksik P, Laharie D, Colombel JF, et al. Ineffectiveness of Lactobacillus johnsonii LA1 for prophylaxis of postoperative recurrence in Crohn's disease: a randomised, double blind, placebo controlled GETAID trial. Gut. 2006;55:842-847. (Pubitemid 43764556)
29. Van Gossum A, Dewit O, Louis E, de Hertogh G, Baert F, et al. Multicenter randomized-controtled clinical trial of probiotics (Lactobacillus johnsonii, LA1) on early endoscopic recurrence of Crohn's disease after ileo-cecal resection. Inflamm Bowel Dis. 2007;13:135-142. (Pubitemid 46806221)
30. Chermesh I, Tamir A, Reshef R, Chowers Y, Suissa A, et al. Failure of Synbiotic 2000 to prevent postoperative recurrence of Crohn's disease. Dig Dis Sci. 2007;52:385-389.
31. Prantera C, Scribano ML, Falasco G, Andreoli A, Luzi C. Ineffectiveness of probiotics in preventing recurrence after curative resection for Crohn's disease: a randomized controlled trial with Lactobacillus GG. Gut. 2002;51:405-409. (Pubitemid 34907710)
32. Wenckert A, Kristensen M, Eklund AE, Barany F, Jarnum S, et al. The long-term prophylactic effect of salazosulphapyridine (Salazopyrin) in primarily resected patients with Crohn's disease. A controlled double-blind trial. Scand J Gastroenterol. 1978;13:161-167. (Pubitemid 8278453)
33. Summers RW, Switz DM, Sessions JT Jr, Becktel JM, Best WR, et al. National Cooperative Crohn's Disease Study: results of drug treatment. Gastroenterology. 1979;77(4 Pt 2):847-869. (Pubitemid 9242048)
34. Ewe K, Herfarth C, Malchow H, Jesdinsky HJ. Postoperative recurrence of Crohn's disease in relation to radicality of operation and sulfasalazine prophylaxis: a multicenter trial. Digestion. 1989;42:224-232. (Pubitemid 19212478)
35. Sutherland LR, Martin F, Bailey RJ, Fedorak RN, Poleski M, et al. A randomized, placebo controlled, double-blind trial of mesalamine in the maintenance of remission of Crohn's disease. The Canadian Mesalamine for Remission of Crohn's Disease Study Group. Gastroenterology. 1997;112:1069-1077.
36. Florent C, Cortot A, Quandale P, Sahmound T, Modigliani R, et al. Placebo-controlled clinical trial of mesalazine in the prevention of early endoscopic recurrences after resection for Crohn's disease. Groupe d'Etudes Therapeutiques des Affections Inflammatoires Digestives (GETAID). Eur J Gastroenterol Hepatol. 1996;8:229-233.
37. Brignola C, Cottone M, Pera A, Ardizzone S, Scribano ML, et al. Italian Cooperative Study Group. Mesalamine in the prevention of endoscopic recurrence after intestinal resection for Crohn's disease. Gastroenterology. 1995;108:345-349.
38. Lochs H, Mayer M, Fleig WE, Mortensen PB, Bauer P, et al. Prophylaxis of postoperative relapse in Crohn's disease with mesalamine: European Cooperative Crohn's Disease Study VI. Gastroenterology. 2000;118:264-273. (Pubitemid 30067499)
39. Caprilli R, Andreoli A, Capurso L, Corrao G, D'Albasio G, et al. Oral mesalazine (5-aminosalicylic acid; Asacol) for the prevention of post-operative recurrence of Crohn's disease. Gruppo Italiano per lo Studio del Colon e del Retto (GISC). Aliment Pharmacol Ther. 1994;8:35-43. (Pubitemid 24208226)
40. Caprilli R, Cottone M, Tonelli F, Sturniolo G, Castiglione F, et al. Two mesalazine regimens in the prevention of the post-operative recurrence of Crohn's disease: a pragmatic, double-blind, randomized controlled trial. Aliment Pharmacol Ther. 2003;17:517-523. (Pubitemid 36384811)
41. Rutgeerts P, Hiele M, Geboes K, Peeters M, Penninckx F, et al. Controlled trial of metronidazole treatment for prevention of Crohn's recurrence after ileal resection. Gastroenterology. 1995;108:1617-1621.
42. Rutgeerts P, Van Assche G, Vermeire S, D'Haens G, Baert F, et al. Ornidazole for prophylaxis of postoperative Crohn's disease recurrence: a randomized, double-blind, placebo-controlled trial. Gastroenterology. 2005;128:856-861. (Pubitemid 40523538)
43. Hellers G, Cortot A, Jewell D, Leijonmarck CE, Löfberg R, et al. Oral budesonide for prevention of postsurgical recurrence in Crohn's disease. The IOIBD Budesonide Study Group. Gastroenterology. 1999:116:294-300.
44. Ewe K, Böttger T, Buhr HJ, Ecker KW, Otto HF. Low-dose budesonide treatment for prevention of postoperative recurrence of Crohn's disease: a multicentre randomized placebo-controlled trial. German Budesonide Study Group. Eur J Gastroenterol Hepatol. 1999;11:277-282.
45. Ardizzone S, Maconi G, Sampietro GM, Russo A, Radice E, et al. Azathioprine and mesalamine for the prevention of relapse after conservative surgery for Crohn's disease. Gastroenterology. 2004;127:730-740. (Pubitemid 39208406)
46. Hanauer SB, Korelitz BI, Rutgeerts P, Peppercorn MA, Thisted RA, et al. Postoperative maintenance of Crohn's disease remission with 6-mercaptopurine, mesalamine, or placebo: a 2-year trial. Gastroenterology. 2004;127:723-729. (Pubitemid 39208405)
47. D'Haens GR, Vermeire S, Van Assche G, Noman M, Aerden I, et al. Therapy of metronidazole with azathioprine to prevent postoperative recurrence of Crohn's disease: a controlled randomized trial. Gastroenterology. 2008;135:1123-1129.
48. Regueiro M, Schraut W, Baidoo L, Kip KE, Sepulveda AR, et al. Infliximab prevents Crohn's disease recurrence after ileal resection. Gastroenterology. 2009;136:441-450.
49. Regueiro M, Schraut W, Baidoo L, Kevin K, Plevy S, et al. Two year postoperative follow up of patients enrolled in the randomized controlled trial of infliximab for prevention of recurrent Crohn's disease. Gastroenterology. Abstract T1207. In press.
50. Sorrentino D, Terrosu G, Avellini C, Maiero S. Infliximab with low-dose methotrexate for prevention of postsurgical recurrence of ileocolonic Crohn's disease. Arch Intern Med. 2007;167:1804-1807. (Pubitemid 47403070)